C (@AshokChander) header
C (@AshokChander) profile picture
Boston, MA
Joined June 2011
Just published @NEJM During Omicron, the 2-shot mRNA vaccine effectiveness among >250,000 children age 5 to 11 years old: vs hospitalizations was very high—83% vs PCR confirmed infections 65% nejm.org/doi/full/10.1056/NE…
36
274
60
771
Bookends to a very fulfilling career: 1st RP patient (Aug 1989) still alive & cancer free @ age 88; last RP (Sep 2021) hit the trifecta 5 weeks post-op. The Emporium is now officially on hiatus. Elvis has left the building... @CleClinicUro @CleClinicNeph #TeamGUKI
15
9
4
193
Too little, too late, too flawed. Sound familiar? UK (and US homology) on the failure of its public health response to #COVID19 press.psprings.co.uk/bmj/may… @bmj_latest by @GabrielScally @Bobbiedoc Kamran Abbasi
3
101
8
165
Congrats @shishirmehrotra and team! Coda @coda_hq now available to all. Love the new mobile experience which turns my docs into slick native apps.
We started Coda to reinvent docs from the ground up. Today we've taken the first major step to realize that vision, and to enable people to create docs that are as powerful as full-fledged apps, with no programming required. See more here. #aDocforMakers youtube.com/watch?v=M2tNj1CY…
2
12
Replying to @LifeSciVC
“Why are we here? We’re here to make medicines that help patients, and this conference week is supposed to rally us all around that mission. But I didn’t hear a lot about patients and impact this year.” – at Manhattan, NY
1
2
9
Replying to @LifeSciVC
“Given the speed-dating nature of most discussions, almost all JPM interactions are superficial at best.”-Amen and thanks for saying what many of us have come to realize regarding the ROI and relevance of attending JPM year after year.
1
1
4
This Boston startup is developing technology using live cell phenotyping for the risk-stratification of #ProstateCancer @Cellanyx goo.gl/MZyWVF
2
2
Predicting pathology provides prostate prognostication stm.sciencemag.org/content/1…
Calling all #FinTech startups: applications for @MassChallengeFT are now open! @MassChallenge’s newest zero-equity accelerator can grow your #startup w/ 1:1 industry partnerships + expert mentors + up to $250K in cash. Apply by 10/12 at 12:00PM ET: https://nitter.cf/t.co/xhvzJyF2sP
5
5
Congrats to @Cellanyx, winner of #SDSW17 @MedStartr Pitch Fest, founded by @Columbia alum @AshokChander. nitter.cf/ColumbiaEship/status/8…
#CUStartup @Cellanyx could be “an industry-wide game changer when it comes to blockbuster diagnostics.” Learn more: goo.gl/NDvM9P
1
1
Thank you to @theNCI @BidenCancer moonshot program for funding our initiative @BCMCancer. Thanks to @PCFnews @PCF_Science helping us lay the groundwork for this critical work on African American prostate cancer through the VA PCF Challenge Grant!
A new $6 million grant from @theNCI awarded to a team of researchers at @bcmhouston @BCMCancer supports study of racial and ethnic disparities in prostate and breast cancers. bcm.edu/news/grants/nci-gran…
1
4
15
Congratulations Jim Allison on winning the 2018 #NobelPrize in Medicine! PCF was an early funder of Allison's #immunotherapy work in #ProstateCancer. Since then, 1000's of patients have been helped, and the promising fields of immunotherapy and precision medicine have ballooned. – at Hermosa Beach, CA
2
51
7
125
A stellar review of #cancer mutations, zooming in on understanding functionality (use of #CRISPR) and evolution/lineage nature.com/articles/s41576-0… @NatureRevGenet by @StanfordMed
From @JFruehauf - Big congratulations for our friends at Cellanyx, founder/CEO @Cellanyx for your publication in Nature Biomedical Engineering ! Great endorsement of your platform! #prostatecancer MassChallenge 2012 winners. @nat…lnkd.in/e_AFMzy lnkd.in/eAhq44U
2
1
I’m waiting for the day I can just stare at somebody and go. Yup. Cancer. – at Pittsburgh, PA
For #cancer, we've been stuck on assessing dead tissue blocks. Now it's time for machine vision of live cells #AI (w/ single cell resolution) nature.com/articles/s41551-0… @NatBME Encouraging results in prostate and breast cancer for prognosis by @AshokChander @Cellanyx & colleagues
2
15
1
21
Congrats to the winners at #SDSW17 @MedStartr pitch contest @Cellanyx, @glyconmedics and Kinaptic. + big shout-out to a great #crowd today!
Cellanyx CSO @AshokChander guest blogs on avoiding #startup catch-22s @masschallenge: ow.ly/casDn #MCFinalist #MC2012
2
1